Ferium-XT

Quick links to important sections

Ferium-XT

Method of action: Antianemic

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ferium-XT

Property Description
Active Ingredients Ferrous Ascorbate, Folic Acid
Form Oral Solid Preparation (Tablet/Capsule)
Pharmacological Class Haematinic Agent
General Purpose Support essential blood formation
Type Fixed-Dose Combination (FDC)

Defining Ferium-XT: Type and Classification

Ferium-XT is fundamentally a Fixed-Dose Combination (FDC) preparation that is classified as a Haematinic Agent. This designation is for medicines primarily used to support the body’s essential processes for forming and maturing healthy blood components. As an oral preparation, commonly available in solid forms like tablets or capsules, it is designed for ingestion via the oral route of administration. The use of this FDC formulation for iron and folate addresses common concurrent nutritional deficits through a streamlined approach. A typical scenario for its general use is in individuals requiring replenishment of both mineral and vitamin reserves to maintain nutritional balance.

Composition: Ferrous Ascorbate and Folic Acid

The two active components in Ferium-XT are the synthetic compounds Ferrous Ascorbate and Folic Acid. Ferrous Ascorbate is a specific salt form of iron where the Ascorbate component (Vitamin C) serves a crucial role: it maintains the iron in its readily absorbable ferrous (Fe^2+) state within the gastrointestinal tract, thereby improving its uptake. Folic Acid is the synthetic version of Vitamin B9, which is also vital for the drug’s effectiveness. The formulation’s unique feature is the specific inclusion of Ferrous Ascorbate, a choice for delivering a superior bioavailability of iron compared to traditional iron salts.

General Purpose of this Haematinic Combination

The general therapeutic purpose of this medicine is to provide the critical resources necessary for the body to maintain normal blood formation. The combination provides elemental Iron for the synthesis of hemoglobin, which ensures effective oxygen transport, while Folic Acid is required for the proper DNA synthesis needed for the rapid division and maturation of new red blood cells. This product is positioned to address the simultaneous need for both nutrients, ensuring comprehensive support for the blood-forming process and nutrient deficiency correction.

What side effects are possible with Ferium-XT?

Possible Side Effects and Safety Information

The safety profile of Ferium-XT, a combination of Ferrous Ascorbate and Folic Acid, is primarily defined by the potential for gastrointestinal disturbances and critical safety constraints outlined in regulatory documents.

Documented Adverse Reactions and Frequency

The most frequently documented adverse effects are classified within Gastrointestinal Disorders. These common reactions include experiencing nausea, vomiting, constipation, diarrhea, and epigastric pain. A highly common and expected physiological change is the presence of dark or black stools (melena), which results from unabsorbed iron and is not typically considered harmful.

Less frequently reported adverse reactions, classified as Rare in some regulatory documents, include generalized allergic sensitization. The severe reaction of Anaphylactic Reaction is also reported, though its frequency is often classified as Not Known.


Serious Adverse Reactions and Safety Constraints

Official labeling carries a major safety warning regarding the risk of fatal accidental overdose with iron-containing products, primarily concerning children under six years of age. Acute, severe iron overdosage is a medical emergency that can lead to severe systemic effects including circulatory collapse and seizures.

Specific regulatory restrictions state that the medicine should be avoided in individuals with pre-existing conditions of iron overload, such as Hemosiderosis and Hemochromatosis. A critical safety note is that the Folic Acid component can potentially obscure the diagnosis of Pernicious Anemia (Vitamin B12 deficiency) by improving hematologic signs while neurological damage progresses. The oral iron component may also aggravate existing inflammatory bowel conditions like peptic ulcer or ulcerative colitis.

Overdose and Emergency Response

Ferium-XT Overdose and when to seek help

Documented Overdose Manifestations

Overdose symptoms are driven by the iron component and begin with signs of severe corrosive injury to the gastrointestinal tract. Documented initial manifestations include vomiting, diarrhea, abdominal pain, and evidence of hemorrhagic gastroenteritis (hematemesis or rectal bleeding). Systemic presentations include lethargy, pallor, cyanosis, tachycardia, and hypotension. Life-threatening outcomes officially include profound metabolic acidosis, acute renal failure, coagulopathy, and circulatory collapse, leading to potential hepatic necrosis and death.

Mandatory Emergency Response

Immediate medical attention must be sought in all cases of suspected overdose. The official regulatory guidance requires emergency hospitalization and continuous monitoring due to the risk of delayed systemic toxicity. Management involves supportive treatment, gastric decontamination procedures, and correction of acid-base imbalance. For severe iron toxicity, specific chelating therapy with Deferoxamine is documented.

Population-Specific Risk

Regulatory warnings emphasize that overdosage poses a serious, life-threatening risk in pediatric patients, and is cited as a leading cause of accidental poisoning fatalities in children under six years of age.

Therapeutic Uses of Ferium-XT

Managing Symptoms of Low Hemoglobin

Ferium-XT is commonly used to help with deficiency states that lead to symptoms related to systemic imbalance. The medicine is applied in addressing conditions marked by systemic or localized discomfort, such as conditions involving episodic or fluctuating manifestations. It supports the patient during difficult episodes by easing the overall burden of symptoms that interfere with daily functioning.


Supporting Increased Nutritional Needs

This supplement is considered relevant in clinical settings that involve heightened systemic burden, particularly when conditions where symptoms may intensify temporarily are present. This includes conditions associated with acute or disruptive episodes where symptoms may intensify temporarily. Ferium-XT may assist with maintaining functional stability when physiological requirements may intensify temporarily, and may be part of symptomatic management during phases where the patient experiences heightened discomfort.

“Applied across domains where additional symptomatic support is needed.”


Addressing Specific Symptom Clusters

Ferium-XT is applied across domains where additional symptomatic support is needed, helping address symptom clusters that may become intense or disruptive over time. These clusters include symptoms related to physical discomfort and symptoms that create noticeable physiological strain. It is relevant for managing the physical signs of nutrient deficiency, contributing to easing the overall symptom load when these symptoms create noticeable physiological strain.

Quick Fact: Supports Management of Symptoms that Interfere with Daily Functioning

Eligibility and Restrictions for Use

Eligibility for Ferium-XT Use: Official Regulatory Information

Regulatory documents define specific population eligibility and restriction rules for Ferium-XT (Ferrous Ascorbate and Folic Acid combination). Use is generally established for adults and adolescents with diagnosed nutritional deficiencies. The medicine is commonly permitted for use during pregnancy and lactation due to increased physiological requirements for iron and folic acid.

Absolute Contraindications

Use is strictly contraindicated for individuals with conditions of iron overload, including Hemosiderosis or Hemochromatosis. It is also prohibited for patients with certain blood disorders, such as Pernicious Anemia and Hemolytic Anemia, as the folic acid component can mask the symptoms of B12 deficiency. Patients with known hypersensitivity to any component must not use the medicine.

Population Restrictions and Cautions

There is a critical regulatory warning regarding infants and young children under 6 years, as accidental iron overdose is a leading cause of fatal poisoning in this age group. Use requires caution in patients with active gastrointestinal conditions (e.g., Peptic Ulcer or Ulcerative Colitis) and in those with undiagnosed anemia. For the elderly population, safety and effectiveness may not be established across all regulatory labels.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Ferium-XT, a combination of Ferrous Ascorbate (Iron) and Folic Acid, has documented interactions primarily governed by the iron component's ability to interfere with absorption. These interactions necessitate specific administration constraints as defined in regulatory labeling.

Pharmacokinetic Absorption Interference

Co-administration of the iron component with numerous oral medicinal products can result in a reduced systemic exposure of the co-administered drug. This is a common pharmacokinetic interaction that requires mandatory temporal separation of doses. Medicines whose absorption is diminished include Fluoroquinolone antibiotics, Tetracycline antibiotics, Levothyroxine for thyroid function, Bisphosphonates, and certain agents for Parkinson's disease such as Levodopa. Antacids and supplements containing calcium or zinc also interfere with iron absorption, requiring administration separation of at least two hours.

Folic Acid and Pharmacodynamic Constraints

The Folic Acid component may reduce the serum levels of certain anticonvulsant drugs like Phenytoin. Conversely, some medicines, such as Trimethoprim and Sulfasalazine, may reduce the effect or interfere with the absorption of Folic Acid itself. Official labeling cautions that Folic Acid is contraindicated in patients with undiagnosed pernicious anemia due to the risk of masking the neurological symptoms associated with Vitamin B12 deficiency.

Mechanism of Action

How Ferium-XT Works: Mechanism of Action

Ferium-XT exerts its effect through the coordinated supply of two essential biochemical requirements for erythropoiesis (Red Blood Cell production).

Substrate Supply: The ferrous iron ( Fe^2+) component functions as a substrate, absorbed across the intestinal epithelium via transporters like DMT1. The iron is then transported to the bone marrow where it is incorporated into the heme ring, a critical step in the formation of hemoglobin. This supports the structural component of oxygen transport.

Cofactor Provisioning: The folic acid component acts as a cofactor for the one-carbon metabolism pathway. Active folate forms are required for the synthesis of purines and pyrimidines, the nucleic acid bases essential for DNA replication. This mechanism supports the cell division and proliferation of erythrocyte precursors.

These two independent, yet necessary, mechanisms concurrently regulate the cellular processes and molecular composition required for the production of mature erythrocytes with adequate hemoglobin saturation, affecting oxygen delivery capacity within the hematopoietic system.

Dosage and Administration Information

Ferium-XT, a Fixed-Dose Combination (FDC) of Ferrous Ascorbate and Folic Acid, is designed exclusively for oral administration and is typically supplied as an oral solid preparation such as a tablet or capsule. The solid form must be swallowed whole with a full glass of water, and instructions advise against crushing, breaking, or chewing the unit. Co-administration should be avoided with absorption-inhibiting substances such as dairy products, coffee, or tea.

For standard adult usage, the typical treatment regimen is one tablet taken once daily, delivering a specific combination of Ferrous Ascorbate and Folic Acid. Higher daily doses may be recommended for prophylaxis during pregnancy to meet heightened nutritional needs. It is advised the medicine not be administered to children under the age of 12.

To achieve optimal absorption of the iron component, the medicine is generally instructed to be taken on an empty stomach, approximately one hour before or two hours after a meal. The duration of use is goal-based, continuing until specific blood parameters are normalized, often requiring therapy until iron stores are replenished. If a dose is missed, it is directed to simply skip the missed dose and resume the normal schedule without taking a double dose.

Recent Clinical Evidence

Ferium-XT: Recent Clinical Evidence


Evidence for Correcting Iron and Folate Deficiencies

Randomized Controlled Trials (RCTs) and systematic reviews are the primary evidence types that have examined the use of Ferium-XT, a Fixed-Dose Combination (FDC) of iron and folic acid, in individuals with concurrent deficiencies. These research efforts mainly monitored hematological biomarkers, such as changes in Hemoglobin (Hb) levels and serum ferritin (a marker of the body's iron stores).

Short-term trials reported measurements of changes in Hemoglobin and ferritin levels in observed populations over defined study periods, such as 12 weeks. Findings describe patterns observed in the studies. Research explored how the observed changes compared alongside single iron salts in some trials. Evidence contributes to understanding how this particular combination was observed in studies exploring changes related to these specific nutrient deficits. Research provides context but the evidence base has limitations; long-term outcomes beyond the initial treatment period are not fully characterized.


Studies on Use During Periods of Increased Nutritional Needs

Clinical trials have also examined the FDC in populations with higher physiological demands, such as pregnant women. The focus was on the evidence structure that was used to study this FDC alongside other preparations. Research describes patterns observed when folic acid was monitored in studies exploring neural tube defects (NTDs). Studies reported how the incidence of maternal anemia evolved in the observed populations when supplementation was provided. Findings indicate that reported data on birth outcomes may show moderate consistency across systematic reviews.


Research Gaps and Areas of Uncertainty

Comparative evidence is lacking for certain head-to-head trials that would compare this specific FDC alongside every other oral iron formulation. Studies focusing on patient-reported outcomes describing perceived discomfort or outcomes reflecting daily functioning or activity level are not always the primary endpoint. These research gaps highlight what is known—and what is still uncertain—about Ferium-XT in the broader evidence landscape.

Frequently Asked Questions (FAQ)

Common questions about Ferium-XT (FAQ)


Q: How can users generally manage constipation while taking this medicine?

Constipation is a common gastrointestinal side effect noted in patient information for oral iron products. To help address this common discomfort, patient information often describes general supportive measures. These typically involve adequate fluid intake, consumption of dietary fiber, and light physical activity.


Q: What is the elemental iron content in Ferium-XT?

The official product labeling for Ferium-XT specifies the amounts of its active ingredients. The dose of Ferrous Ascorbate is listed as 100 mg, which typically corresponds to 30 mg of elemental iron. It also contains 1.5 mg of Folic Acid.


Q: Does Ferium-XT also contain Vitamin B12 (mecobalamin)?

Standard Ferium-XT formulations contain Ferrous Ascorbate and Folic Acid as the main active ingredients. However, product lines often feature variant formulations, such as 'Ferium XT Plus Suspension,' which may include additional components like Vitamin B12 (Mecobalamin).


Q: Does the scientific evidence show that Ferium-XT helps prevent neural tube defects?

Authoritative health organizations have established that taking the nutrient folic acid daily before and during early pregnancy can help prevent neural tube defects (NTDs). As Ferium-XT is a combination product that includes folic acid, it provides this nutrient which is considered essential for supporting pregnancy health.


Q: What kind of studies support the use of Ferium-XT for iron deficiency?

The use of iron and folic acid combination products is supported by clinical studies and medical consensus. Research efforts typically involve monitoring changes in hematological markers, such as hemoglobin and serum ferritin (iron storage markers), to document the medicine's role in correcting concurrent nutrient deficiencies.


Q: Is Ferium-XT considered safe for women who are breastfeeding?

Official patient information indicates that the iron and folic acid combination is typically permitted for use during breastfeeding. This is due to the increased physiological requirements for these nutrients during this period, provided the medicine is used to address a diagnosed nutritional deficiency.


Q: Is there a specific formulation of Ferium-XT available for children?

Yes, regulatory product information shows that Ferium-XT is available in more than one physical form. In addition to the solid preparation (tablet/capsule), it is also available in a liquid form, such as a syrup or suspension, which is generally used for children.


Q: Is it safe to consume alcohol while taking Ferium-XT?

Patient information indicates that excessive or chronic consumption of alcohol may interfere with the body's ability to absorb folic acid, which may potentially reduce the medicine’s effect. Alcohol intake can also cause irritation of the stomach lining, which may be heightened when combined with oral iron supplements.


Q: Does Ferium-XT interfere with the absorption of other nutrients like zinc?

Regulatory documents describe a reciprocal absorption relationship between iron and other minerals. While the nutrient zinc is noted to interfere with the absorption of the iron component in Ferium-XT, official sources generally indicate that doses are required to be separated by at least two hours to manage this interaction.


Q: Are there any food restrictions besides avoiding tea and coffee while on this treatment?

In addition to avoiding dairy products, tea, and coffee, patient information often advises against consuming high-fiber foods around the time of dosing. Foods rich in oxalate, such as spinach, beetroot, and chocolate, are also sometimes cautioned against as they may reduce iron absorption.


Q: Are there different forms of Ferium-XT (e.g., drops, syrup, tablet)?

According to product summaries, Ferium-XT is commercially available as both an oral solid preparation, such as a tablet or capsule, and in a liquid dosage form, such as a syrup or suspension. These different forms allow for various administration methods.


Q: If taking Ferium-XT causes stomach upset, is it better to take it with food?

Official instructions generally recommend taking the medicine on an empty stomach to achieve optimal iron absorption. However, if persistent gastrointestinal discomfort or stomach upset occurs, official guidance states that the medicine may be administered with food to minimize irritation.


Q: What happens in the body if a person has a deficiency of Folic Acid?

Folic acid is essential for DNA synthesis and proper cell division, especially for rapidly dividing cells like red blood cells. A deficiency in folic acid can lead to a type of blood disorder called megaloblastic anemia. Severe deficiency may also be associated with neuropsychiatric symptoms.


Q: Does Ferium-XT support general immunity?

The Folic Acid component is generally recognized for its role in maintaining a healthy immune system, as it is crucial for cell division and growth. The overall function of the combination product is to correct nutritional deficits, which is associated with managing physical weakness and fatigue.

How should Ferium-XT be stored and disposed of?

Official Storage and Disposal Requirements

Ferium-XT must be stored strictly according to its regulatory label to maintain stability and prevent accidental harm.

Storage Component Requirement
Temperature Store at room temperature (15 C to 30 C); keep away from excessive heat.
Protection Keep in a cool, dry place; protect from light and moisture.
Packaging Keep in the original container, tightly closed.
Child Safety WARNING: Keep this product out of reach and sight of children. Accidental overdose of iron is a leading cause of fatal poisoning in children under six.

For disposal, unused or expired medication should not be flushed down a toilet or poured down a drain. Utilize a medicine take-back program or follow official safe household disposal procedures. Before discarding, all personal information on the label should be removed or scratched out.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ferium-XT found in:

A-Z Index: